12 April, 2017
Through this new partnership, Fortress Diagnostics can offer laboratories new opportunities for the participation in internationally recognised External Quality Assessment (EQA) programs.
These programs enable laboratories to compare their results with other laboratories in order to maintain and improve the quality of the analytical performance, complementing the daily use of internal quality controls manufactured and offered by Fortress Diagnostics.
Fortress Diagnostics has selected the Clinical Chemistry program with 31 analytical parameters and the Infectious Disease Program (anti-HIV, anti-HCV, anti-HBc and HBsAg) for the launch of this cooperation project. Additional programs will be offered in the future and can be added upon request.
If you would like to join ESfEQA, or to find out more information, please contact us.
- ENDS -
About Fortress Diagnostics
Fortress Diagnostics is a multi award-winning global provider of in vitro diagnostics (IVDs). Fortress Diagnostics develops, manufactures and supports an extensive portfolio of clinical diagnostic tests from their ISO 13485:2016-accredited facility in the United Kingdom.
Through their global distribution network they provide highly accurate medical testing solutions to immunology, haematology and serological laboratories in hospitals, medical centres, clinics, blood banks and research institutions in over 100 international markets.
The European Society for external quality assessment (ESfEQA) offers a variety of external quality tests to medical laboratories in the areas of biochemistry, hematology, immunology and microbiology. Monthly and quarterly programs from ESfEQA are available to the users and managers responsible for quality standards in medical laboratories. The ESfEQA quality assessment samples and the ESfEQA service are characterised by a high quality, reliability, simplicity of use and flexibility.
Visit the ESfEQA Website